Xcout Intel
Agenus Inc. competitors & alternatives
The 12 closest competitors and alternatives to Agenus Inc. among biotechnology companies — ranked by similarity to what Agenus Inc. actually does, not by market-cap band.
Subscribe to see Agenus Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Agenus Inc.
Agenus Inc. is a biotechnology company headquartered in Lexington, Massachusetts, focused on the discovery and development of better immunotherapies and cancer treatments.
Agenus Inc. at a glance
Agenus Inc. is a biotechnology company headquartered in Lexington, United States. It is publicly listed (AGEN) with a market capitalisation of $249M. Xcout tracks 22 named people at Agenus Inc., including Jennifer S. Buell (Director and President & Chief Executive Officer of MiNK Therapeutics).
Agenus Inc. leadership
- Jennifer S. BuellDirector and President & Chief Executive Officer of MiNK Therapeutics
- Steven J. O'DayChief Medical Officer
- Craig WinterChief Information Officer
- Robin G. TaylorChief Commercial Officer
- Robin Taylor, Ph.D.Chief Commercial Officer
- Stefanie Perna-NacarChief Communications & Government Relations Officer
16 more named people on record for Agenus Inc., with roles, board committees and tenure — see the full roster →
Top 12 Agenus Inc. competitors
Ranked by semantic similarity — how close each company is to Agenus Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Curis, Inc. is a biotechnology company headquartered in Lexington, Massachusetts. The company is engaged in the research and development of drug candidates for the treatment of human cancers.
Biotech
MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natural killer T (iNKT) cell therapies. These treatments are allogeneic and designed to be "off-the-shelf," providing readily available options for combating various cancers and conditions rooted in immune system dysfunction. The company's leading investigational therapy is AGENT-797. This product is an allogeneic, ready-to-use iNKT cell therapy, presently in Phase 1 clinical studies to assess its effectiveness against different forms of myeloma. Established in 2017, the company was previously known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. is headquartered in New York, New York, and operates as a subsidiary of Agenus Inc.
Similar biotechnology company
CureLab Oncology Inc. is a clinical-stage biotechnology company headquartered in the greater Boston area that develops new anti-cancer biologics, with its lead product being the immuno-oncology agent Elenagen.
Similar biotechnology company
Accent Therapeutics, Inc. is a biopharmaceutical company headquartered in Lexington, Massachusetts, focused on translating scientific research into novel therapeutics. The company conducts clinical trials, such as Phase 1/2 studies, targeting oncology and other serious diseases.
Similar biotechnology company
Affini-T Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, specializing in the development of precision immunotherapies and T-cell therapies for cancer patients.
Similar biotechnology company
Triana Biomedicines, Inc. is a private biotechnology company focused on targeted molecular glue discovery. The company is headquartered in Lexington, Massachusetts.
Similar biotechnology company
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, with an additional office in Belgium. The company focuses on discovering and developing novel immuno-oncology therapeutics for cancer treatment.
Similar biotechnology company
Alloplex Biotherapeutics, Inc. is a privately owned clinical-stage cellular therapeutics company with headquarters and laboratories located in Woburn, Massachusetts, developing robust platforms for treating cancer.
Similar biotechnology company
Checkmate Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on developing proprietary technology to stimulate the immune system to combat cancer.
Biotech
ImmunityBio, Inc. is a public clinical-stage immunotherapy company headquartered in San Diego, California. As a member of the NantWorks ecosystem, it focuses on developing next-generation cancer vaccines and immunotherapies.
Similar biotechnology company
A2 Biotherapeutics, Inc. is a clinical-stage biotechnology research company headquartered in Agoura Hills, California. The company develops precision T-cell therapies designed to target solid tumors while sparing healthy tissue.
Similar biotechnology company
Boston Immune Technologies and Therapeutics, Inc. (BITT) is a company headquartered in Winchester, Massachusetts, that specializes in the development of cancer treatments and therapeutics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Agenus Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Agenus Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →